Company Overview
More
Micro Chuangxintong Medical Technology Co., Ltd. is a Chinese investment holding company mainly engaged in the medical device industry. The company is mainly engaged in the R & D and commercialization of transcatheter and surgical solutions in the field of valvular heart disease. The company's main products include the first generation transcatheter aortic valve implantation (TAVI) product "VitaFlow" and the second generation TAVI product "VitaFlow II". The company mainly does business in the domestic market.
CEO： Qiyi Luo
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
02160 CARDIOFLOW-B
2.330+0.030+1.30%
Closed 05/23 16:08 CCT
High
2.360
Open
2.340
Turnover
4.69M
Low
2.290
Pre Close
2.300
Volume
2.02M
Price Forecast
No Data
News
Comment
CARDIOFLOW-B: 2021 Annual Report
CARDIOFLOW-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: 2021 Interim Report
CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2021
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: FORECASTED INTERIM RESULTS - DECREASE IN NET LOSS
CARDIOFLOW-B: Annual Report 2020
CARDIOFLOW-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2020
CARDIOFLOW-B: DATE OF BOARD MEETING
No More